IMV
IMV is a Canadian biopharmaceutical company focused on developing immunotherapies for serious human diseases using its proprietary lipid-based delivery system, which the company calls DPX.
B2X
Business Model
Commerce
Licensing
CIK Number
Legal Name
IMV Inc.
Company Operating Status
Active
Contact Page URL
Country
Crunchbase URL
Fax Number
+1 (902) 492-0888
0
Founded Date
2000
Full Address
130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia, B3B 2C4 Canada
0
2875 Boulevard Laurier Delta 1, Suite 220 Québec, Québec, G1V 2M2
0
10 Rogers Street Suite 120 and 121 Cambridge MA 02142-1288
0
Headquarters
Latest Funding Round Date
January 3, 2022
Latest Funding Type
LinkedIn URL
NAICS Code
325,412
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Phone Number
+19024921819
0
Pitchbook URL
Place of Incorporation
Previous Name
Immunovaccine Inc.
0
SIC Code
2,834
0
Exchange
Stock Symbol
IMV
0
Ticker Symbol
IMV
Total Funding Amount (USD)
55,349,998
Twitter URL
Official Website
YouTube Channel
Find more companies like IMV
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.